Further support for a potential beneficial role for ERβ activation in PCa comes from a recent study by Mak and colleagues, who stimulated ERβ in prostate cancer cells and showed inhibition of epithelial-mesenchymal transition and invasion [37]. Here, ESR2 is linked to prostate cancer.